THAR: Total dodolan perusahaan tharimmune.com

tharimmune.com - logo grafis emiten THAR

Tharimmune, Inc. (THAR) is developing oncology drugs through strategic in-licensing of assets, which drives its growth dynamics. While portfolio diversification covers liver cancer and pruritus therapies, the lack of profitability leaves the business dependent on venture capital investments. The company's sales volatility clearly demonstrates this stage, and the value of 0.00 describes the current level of operating inflows, confirming the early-stage trial phase.

Tharimmune Corp (THAR) - Pendapatan lan volume dodolan saka 21.02.2024 nganti 18.02.2026

Rincian metrik komprehensif lan analitis Tharimmune Corporation (THAR)

- rega pasar lan target rega analis:
Analisis komprehensif perusahaan:THAR tharimmune.com
Barang unggulan Tharimmune Corp

This indicator captures the aggregate daily cash flow from product sales, determining the real-time speed of operating income generation. By analyzing the sales dynamics of Tharimmune, Inc. (THAR), investors assess the stability of market share and the business's ability to generate liquidity without relying on borrowed funds. The metric is sensitive to consumer demand, where stagnating values signal a risk of capital freeze. For the biotech startup Tharimmune, Inc. (THAR), such volumes confirm the effectiveness of attracting talent into immuno-oncology.

Analisis perusahaan pesaing

Pendapatan perusahaan ONC|Pendapatan lan volume dodolan HALO|RVMD (Revolution Medicines, Inc.) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Ascentage Pharma Corp AAPG|Total volume dodolan perusahaan CG Oncology, Inc.|URGN - Pendapatan perusahaan|Bicara Therapeutics Inc. (BCAX) - Dodolan perusahaan|Personalis Inc (PSNL) - Pendapatan perusahaan|ERAS - Pendapatan reged perusahaan|DCTH (Delcath Systems Inc) - Pendapatan lan volume dodolan|Pendapatan perusahaan YMAB|Pendapatan lan volume dodolan AURA|Pendapatan perusahaan CADL (Candel)|Accuray, Inc. - Dodolan perusahaan|SELLAS Life Sciences Group Inc. - Pendapatan perusahaan|ACTU: Dodolan perusahaan|Total pendapatan perusahaan Citius Oncology Inc|HURA: Pendapatan lan volume dodolan|TARA: Total dodolan perusahaan|FATE (fatetherapeutics.com) - Pendapatan lan volume dodolan|Dodolan perusahaan Aadi Bioscience Inc (WHWK)|Pendapatan lan volume dodolan TCRX|CSBR - Total pendapatan perusahaan|Pendapatan lan volume dodolan XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Total pendapatan perusahaan|OSTX: Dodolan perusahaan|Pendapatan dodolan perusahaan RADX (Radiopharm Theranostics)|Artiva (ARTV) - Pendapatan perusahaan|ANL: Total dodolan perusahaan|VERU (Veru Corporation) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Tempest Therapeutics, Inc. TPST|Pendapatan lan volume dodolan XLO|Renovaro - Volume dodolan perusahaan|Pendapatan perusahaan Mural Bio MURA|KAPA: Volume dodolan perusahaan|OnKure Therapeutics - Pendapatan lan volume dodolan|Pendapatan reged perusahaan w2.cytomed.sg GDTC|CRIS: Pendapatan lan volume dodolan|Dodolan perusahaan Apollomics Inc.|ADVB (Advanced Biomed Corp) - Pendapatan lan volume dodolan|Dodolan perusahaan Genprex, Inc (GNPX)|Pendapatan lan volume dodolan CLDI|SBFM: Pendapatan tahunan perusahaan|Pendapatan lan volume dodolan XBIO (xeneticbio.com)|Pendapatan lan volume dodolan Salarius Pharmaceuticals Inc SLRX|purple-biotech.com - Pendapatan lan volume dodolan|Total pendapatan perusahaan American Oncology Network, Inc.|BGNE: Pendapatan lan volume dodolan|Dodolan perusahaan checkpointtx.com|Pendapatan perusahaan Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Pendapatan reged perusahaan|Pendapatan perusahaan Ikena (IKNA)|NTBL - Total pendapatan perusahaan|Pendapatan perusahaan viracta.com VIRX|morphosys.com (MOR) - Total pendapatan perusahaan|NAYA Biosciences Inc - Pendapatan lan volume dodolan|AAPGV: Pendapatan perusahaan